Skip to content

Gregory Spangler, MD

NPI 1780606046ActiveIndividual· Internal Medicine, Geriatric Medicine· Kokomo, IN

Internal Medicine, Geriatric Medicine (MD) in Kokomo, Indiana, trained at Indiana University School of Medicine (class of 1978). Their prescriptions cost Medicare Part D more than their services did: $2,264,937 for 16,656 claims, against $52,568 paid for services in 2024. Novo Nordisk Inc was the largest of 29 companies reporting payments in 2025, $6,806 in all, mostly food and beverage.

Overview

NPI1780606046
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedJul 24, 2006
Last updated in NPPESNov 27, 2023
Certified by providerSep 16, 2020

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Geriatric Medicine (IN)
Accepts assignmentYes (participating)

Medicare services in 2024

Medicare patients285
Services billed1,694 across 45 procedure codes
Paid by Medicare$52,568

Part D prescriptions in 2024

Prescriptions (claims)16,656 · 33,061 30-day fills
Patients978
Total drug cost$2,264,937
Generic share84% of claims

Medicare sources and data years

Education and affiliations

Medical schoolIndiana University School of Medicine
Graduation year1978
Medicare specialtyGeriatric Medicine
Secondary specialtiesFamily Practice
TelehealthOffers telehealth

Medical group

Hospital affiliations

Other facilities

Source: CMS Care Compare

Industry payments (Open Payments)

  • 2025$6,806 · 364 payments from 29 companies
  • 2024$5,701 · 292 payments from 32 companies

Top paying companies in 2025

CompanyAmountPayments
Novo Nordisk Inc$746.9435
Astrazeneca Pharmaceuticals LP$725.8070
Abbvie Inc.$697.3141
Pfizer Inc.$689.5147
Vanda Pharmaceuticals Inc.$566.5917

What the 2025 payments were for

  • Food and Beverage$6,801 · 363 payments
  • Education$5.55 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records